26Serious

Arlind Ajeti

Arlind Ajeti

Ask VT AI

View News Summary

Tyreek Hill's season-ending injury casts doubt on his NFL future, as he ponders retirement and the Dolphins face a difficult decision on his contract.
Target to cut 1,800 corporate roles, including 1,000 layoffs, to simplify structure and accelerate priorities.
Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Tyreek Hill's season-ending injury casts doubt on his NFL future, as he ponders retirement and the Dolphins face a difficult decision on his contract.
Target to cut 1,800 corporate roles, including 1,000 layoffs, to simplify structure and accelerate priorities.
Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Arlind Ajeti